Merck made a move on Endocytes PhaseIII ovarian cancer treatment vintafolide tonight $120M upfront potential $800M on future milestones. Endocytes boosted up 100% but considering even at that point it's market caps less than PRR's......
Anyway as for dissappointment i never expected much from NASDAQ as i've posted for a long time despite people hypeing the bejeebers about every day of the week for over a year lol....
nasdaq trading-what a disappointment, page-9
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
-0.015(4.23%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 35.8¢ | 33.5¢ | $1.374M | 3.957M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 95461 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 48512 | 1 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |